Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 85, Issue -, Pages 102-116Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2017.04.023
Keywords
Maternal care; Development; Offspring; Perinatal depression; SSRI; Pregnancy; Stress; Play behavior; Social interaction; Reproductive behavior; Antidepressant; Sex differences; Serotonin; Maternal stress; Maternal anxiety
Categories
Funding
- Brain AMP
- Behavior Foundation NARSAD
- Region Bretagne (SAD)
- Rennes Metropole
- VEGA (Slovak Grant Agency) [2/0168/15]
Ask authors/readers for more resources
Recent research has linked early life exposure to selective serotonin reuptake inhibitor medications (SSRls) to modifications of social behaviors in children. Serotonin is a key regulator of neurodevelopment, social behaviors and mental health, and with the growing use of SSRIs to treat maternal affective disorders during the perinatal period, questions have been raised about the benefits and risks of perinatal SSRI exposure on the developing child. This review will highlight how perinatal SSRIs affect maternal care and neurodevelopmental outcomes related to social affiliative behaviors in offspring; such as play behaviors, social interactions, reproductive behaviors, and maternal care of the next generation. We will also review how early life exposure to SSRIs can alter related neurobiology, and the epigenome. Both clinical research and findings from animal models will be discussed. Understanding the impact of perinatal SSRIs on neurobehavioral outcomes will improve the health and well-being of subsequent generations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available